Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 604

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 604
---
           |  18,304 |
| Treasurer and Secretary             |     |      |      |     |            |         |     |          |   |     |            |   |     |                  |        |    |     |           |         |
| Stephen Ma                          |     |      | 2024 |     |            | 128,308 |     |          | — |     |            | — |     |                  |  8,884 | -1 |     |           | 137,192 |
| Anticipated Chief Financial Officer |     |      |      |     |            |         |     |          |   |     |            |   |     |                  |        |    |     |           |         |

| (1) | Represents (i) matching contributions made under the Company’s 401(k) plan, (ii) health insurance premiums paid by Semnur and (iii) life insurance premiums paid by Semnur. |

Narrative Disclosure to Summary Compensation Table During the year ended December 31, 2024, Semnur had only two named executive officers that provided services to Semnur: Jaisim Shah, Semnur’s Chief Executive Officer and Henry Ji, Ph.D., Semnur’s Treasurer and Secretary. Scilex’s Chief Financial Officer, Stephen Ma, also provided services to Semnur during such time but is not currently an executive officer of Semnur. However as Semnur anticipates that Mr. Ma will serve as Semnur’s Chief Financial Officer following the closing of the Business Combination, Semnur is including Mr. Ma in its Summary Compensation Table below. 367

As Semnur is a majority owned subsidiary of Scilex and executives of Scilex are required to provide services to Scilex’s subsidiaries, neither Dr. Ji nor Mr. Shah nor Mr. Ma has received any additional cash or equity compensation from Semnur for services rendered to Semnur for the year ended December 31, 2024 and Semnur has not entered into any employment agreements with Dr. Ji, Mr. Shah or Mr. Ma. Instead, the costs associated with the time spent by Dr. Ji, Mr. Shah and Mr. Ma, and any other employees of Scilex, working on matters for Semnur is allocated to Semnur. These costs are then included in Semnur’s operating expenses as either research and development expenses, if such individual is engaged in research